234 Results for "

tak-

" in MedChemExpress (MCE) Product Catalog:
Products (234)

234 Results for "tak-" in MCE Product Catalog:

524
524 Publications Verification
Cat. No.: HY-11109
CAS No.: 243984-11-4
Purity:  98.92%
Synonyms: tak-242; CLI-095
Resatorvid (TAK-242) is a selective Toll-like receptor 4 (TLR4) inhibitor. Resatorvid inhibits NO, TNF-α and IL-6 production with IC50s of 1.8 nM, 1.9 nM and 1.3 nM, respectively. Resatorvid downregulates expression of TLR4 downstream signaling molecules MyD88 and TRIF. Resatorvid inhibits autophagy and plays pivotal role in various inflammatory diseases .
loading...
    loading...
89
89 Cited Publications
Cat. No.: HY-100487
CAS No.: 1450833-55-2
Purity:  98.38%
Synonyms: MLN7243
Research Areas:  

Cancer

TAK-243 (MLN7243) is a first-in-class, selective ubiquitin activating enzyme, UAE (UBA1) inhibitor (IC50=1 nM), which blocks ubiquitin conjugation, disrupting monoubiquitin signaling as well as global protein ubiquitination. TAK-243 (MLN7243) induces endoplasmic reticulum (ER) stress, abrogates NF-κB pathway activation and promotes apoptosis .
loading...
    loading...
56
56 Cited Publications
Cat. No.: HY-13328
CAS No.: 1224844-38-5
Purity:  99.63%
Synonyms: INK-128; MLN0128; tak-228
Target:  

mTOR Autophagy

Research Areas:  

Cancer

Sapanisertib (INK-128; MLN0128; TAK-228) is an orally available, ATP-dependent mTOR1/2 inhibitor with an IC50 of 1 nM for mTOR kinase.
loading...
    loading...
34
34 Cited Publications
Cat. No.: HY-111789
CAS No.: 1858276-04-6
Purity:  98.56%
Synonyms: tak-981
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology Cancer

Subasumstat (TAK-981) is a first in class and selective inhibitor of the SUMOylation enzymatic cascade, with potential immune-activating and antineoplastic activities .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-12686
CAS No.: 253863-19-3
Purity:  99.30%
Synonyms: FR148083; L783279; LL-Z 1640-2
5Z-7-Oxozeaenol is a natural anti-protozoan compound from fungal origin, acting as a potent irreversible and selective inhibitor of TAK1 and VEGF-R2, with IC50s of 8 nM and 52 nM, respectively.
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-103490
CAS No.: 1111556-37-6
Purity:  99.41%
Synonyms: EDHS-206
Target:  

MAP3K Apoptosis

Takinib (EDHS-206) is an orally active and selective TAK1 inhibitor (IC50=9.5 nM), more than 1.5 log more potent than the second and third ranked targets, IRAK4 (120 nM) and IRAK1 (390 nM), respectively. Takinib is an inhibitor of autophosphorylated TAK1 that non-competitively binds within the ATP binding pocket. Takinib induces apoptosis following TNFα stimulation in cell models of rheumatoid arthritis and metastatic breast cancer. Takinib is also a P. falciparum protein kinase 9 (PfPK9) inhibitor (KD(app) of 0.46 μM) .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-15434
CAS No.: 1315355-93-1
Purity:  99.35%
Target:  

MAP4K MAP3K

Research Areas:  

Inflammation/Immunology Cancer

NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-10480
CAS No.: 1000413-72-8
Purity:  98.97%
Synonyms: tak-875
Research Areas:  

Metabolic Disease

Fasiglifam (TAK-875) is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 72 nM.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-13406
CAS No.: 229005-80-5
Purity:  99.89%
Synonyms: takeda 779
Target:  

CCR HIV CXCR

TAK-779 is a potent and selective nonpeptide antagonist of CCR5 and CXCR3, with a Ki of 1.1 nM for CCR5, and effectively and selectively inhibits R5 HIV-1, with EC50 and EC90 of 1.2 nM and 5.7 nM, respectively, in MAGI-CCR5 cells.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-100888
CAS No.: 1330782-76-7
Purity:  99.94%
Synonyms: tak-931
Target:  

CDK

Research Areas:  

Cancer

Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM. Simurosertib has anti-cancer activity .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B1829
CAS No.: 312-93-6
Synonyms: Dexamethasone 21-phosphate
Dexamethasone phosphate (Dexamethasone 21-phosphate) is a prodrug form of the glucocorticoid Dexamethasone (HY-14648). Dexamethasone phosphate is prepared by introducing a phosphate ester group to the hydroxyl group at position 21 of the Dexamethasone molecule. Dexamethasone phosphate inhibits LPS (HY-D1056)-induced degradation of IRAK-1 and IRAK-4, and blocks LPS-induced activation of TRAF6, p-TAK1 and p-JNK. Dexamethasone phosphate inhibits the secretion of RANTES, TGF-β1 and NO, promotes the production of MIP-1α and IL-10, and blocks microglial migration. Dexamethasone phosphate is almost completely converted to Dexamethasone in rat blood, and supports transdermal delivery via iontophoresis. Dexamethasone phosphate can be used in research related to steroid-dependent ulcerative colitis, chemotherapy-induced vomiting, allergic asthma and acute colitis (inflammatory bowel disease) .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B1829A
CAS No.: 2392-39-4
Synonyms: Dexamethasone 21-phosphate disodium
Dexamethasone phosphate (Dexamethasone 21-phosphate) disodium is a prodrug form of the glucocorticoid Dexamethasone (HY-14648). Dexamethasone phosphate disodium is produced by introducing a phosphate ester group at the 21-position of the Dexamethasone molecule, forming a salt with sodium ions, thereby significantly improving water solubility. Dexamethasone phosphate disodium inhibits LPS (HY-D1056)-induced degradation of IRAK-1 and IRAK-4, and blocks LPS-induced activation of TRAF6, p-TAK1 and p-JNK. Dexamethasone phosphate disodium inhibits the secretion of RANTES, TGF-β1 and NO, promotes the production of MIP-1α and IL-10, and blocks microglial migration. Dexamethasone phosphate disodium is almost completely converted to Dexamethasone in rat blood, and supports transdermal delivery via iontophoresis. Dexamethasone phosphate disodium can be used in research related to steroid-dependent ulcerative colitis, chemotherapy-induced vomiting, allergic asthma and acute colitis (inflammatory bowel disease) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-135815
CAS No.: 1847461-43-1
Purity:  99.60%
Synonyms: tak-788; AP32788
Target:  

EGFR

Research Areas:  

Cancer

Mobocertinib (TAK-788) is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib can be used in NSCLC research .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-10456
CAS No.: 303162-79-0
Purity:  99.76%
Target:  

p38 MAPK Casein Kinase Wnt

Research Areas:  

Inflammation/Immunology

TAK-715 is an orally active and potent p38 MAPK inhibitor with IC50s of 7.1 nM, 200 nM for p38α and p38β, respectively. TAK-715 inhibits casein kinase I (CK1δ/ε) to regulate activation of Wnt/β-catenin signaling. TAK-715 shows good significant efficacy in a rat arthritis model .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-135815A
CAS No.: 2389149-74-8
Purity:  99.83%
Synonyms: tak-788 succinate; AP32788 succinate
Target:  

EGFR

Research Areas:  

Cancer

Mobocertinib (TAK-788) succinate is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib succinate potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib succinate can be used in NSCLC research .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-A0014
CAS No.: 196597-26-9
Synonyms: tak-375
Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-15246
CAS No.: 1096708-71-2
Purity:  99.89%
Synonyms: tak-580; MLN 2480; BIIB-024
Target:  

Raf

Research Areas:  

Cancer

Tovorafenib (TAK-580, MLN 2480) is an orally active and selective inhibitor of pan-Raf kinase. Tovorafenib can be used for the study of glioma .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-13501
CAS No.: 366017-09-6
Purity:  99.76%
Synonyms: tak-165
Target:  

EGFR

Research Areas:  

Cancer

Mubritinib (TAK-165) is a potent and selective EGFR2/HER2 inhibitor with an IC50 of 6 nM.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-14882
CAS No.: 497223-25-3
Purity:  99.51%
Synonyms: tak-652; TBR-652
Target:  

CCR HIV

Research Areas:  

Infection Endocrinology

Cenicriviroc (TAK-652) is an orally active, dual CCR2/CCR5 antagonist, also inhibits both HIV-1 and HIV-2, and displays potent anti-inflammatory and antiinfective activity .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-14882A
CAS No.: 497223-28-6
Purity:  99.04%
Synonyms: tak-652 Mesylate; TBR-652 Mesylate
Target:  

CCR HIV

Cenicriviroc Mesylate (TAK-652 Mesylate) is a dual CCR2/CCR5 antagonist, also inhibits both HIV-1 and HIV-2, and displays potent anti-inflammatory and antiinfective activity.
loading...
    loading...